International Journal on Science and Technology

E-ISSN: 2229-7677   •   Impact Factor: 9.88

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 16 Issue 2 April-June 2025 Submit your research before last 3 days of June to publish your research paper in the issue of April-June.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 16 Issue 2
2025

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Revolutionizing Cell and Gene Therapy Delivery Through AI: A Supply Chain Perspective

Author(s) Sri Santhosh Hari
Country United States
Abstract Cell and gene therapies represent a revolutionary advancement in personalized medicine, offering unprecedented potential for treating previously incurable diseases through genetic modifications and cellular reprogramming. However, the complex manufacturing and distribution processes required for these therapies introduce significant challenges that conventional pharmaceutical supply chains are ill-equipped to handle. This article explores how artificial intelligence technologies are transforming the CGT supply chain, addressing critical challenges in manufacturing variability, production scheduling, quality control, and distribution logistics. By integrating machine learning algorithms, predictive analytics, and real-time monitoring systems, CGT manufacturers can enhance process control, optimize resource allocation, reduce product wastage, and ultimately improve patient outcomes. The integration of these complementary innovations creates new possibilities for overcoming longstanding barriers to CGT accessibility, affordability, and reliability, potentially accelerating the evolution of personalized medicine from an aspirational concept to a clinical reality for patients worldwide.
Keywords Keywords: Artificial Intelligence, Biomanufacturing, Cell Therapy, Gene Therapy, Personalized Medicine
Field Computer
Published In Volume 16, Issue 2, April-June 2025
Published On 2025-04-02
Cite This Revolutionizing Cell and Gene Therapy Delivery Through AI: A Supply Chain Perspective - Sri Santhosh Hari - IJSAT Volume 16, Issue 2, April-June 2025.
View / Download PDF File

Share this



CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJSAT DOI prefix is
10.71097/IJSAT

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 15 Isu 4Cover Page Vol 15 Isu 3Cover Page Vol 15 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJSAT
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us Message on WhatsApp +91-9687-182-185 editor@ijsat.org